About Company
Founded in 1990 and headquartered in Dublin, Ireland, ICON plc offers a comprehensive range of services that span the entire lifecycle of product development. These services include clinical research, consulting, commercialization, and laboratory services. ICON is recognized for its expertise in various therapeutic areas such as oncology, cardiovascular diseases, central nervous system disorders, and more. The company has developed a significant number of the world's top-selling drugs and is committed to accelerating the development of new therapies that improve patient outcomes.
ICON plc is a global, Irish-based company specializing in outsourced clinical development and commercialization services for the pharmaceutical, biotechnology, and medical device industries, providing consulting and expertise across the entire product development lifecycle, with a focus on accelerating the development of new drugs and devices to improve patient lives; they are considered one of the world's leading Contract Research Organizations (CROs) with a large global network of offices and employees across multiple countries.
Key points about ICON:
-
Focus area:
Providing consulting, clinical development, and commercialization services to pharmaceutical, biotech, and medical device companies.
-
Global reach:
Operates in numerous countries with a large international workforce.
-
Services offered:
A wide range of services across the entire drug development lifecycle, including clinical trial design, patient recruitment, data management, and regulatory support.
-
Reputation:
Recognized as a leading CRO in the industry, having contributed to the development of many top-selling drugs.
Important details about ICON:
-
Headquarters: Dublin, Ireland
-
Stock exchange listing: Nasdaq
-
Employee count: Approximately 41,900 employees
-
Key areas of expertise: Diverse therapeutic areas including oncology, immunology, cardiovascular, and neurology